Clinical Edge Journal Scan

Continuation of screening endoscopy beyond age 75 prevents CRC incidence and death


 

Key clinical point: Screening lower gastrointestinal tract endoscopy in adults older than 75 years with no substantial comorbidities was associated with a lower risk for colorectal cancer (CRC) incidence and survival gain, regardless of screening history.

Major finding: Irrespective of prior screening history, endoscopic screening after 75 years of age was associated with a significantly lower incidence of CRC (hazard ratio [HR], 0.61; 95% confidence interval [CI], 0.51-0.74) and CRC-related mortality (HR, 0.60; 95% CI, 0.46-0.78), particularly in individuals without cardiovascular diseases or substantial comorbidities.

Study details: Findings are from an analysis of 2 prospective cohorts of 56,374 U.S. adults who reached 75 years of age during follow-up.

Disclosures: The study was supported by grants from the National Institutes of Health, a Stuart and Suzanne Steele Massachusetts General Hospital (MGH) Research Scholar award (Dr. Chan), and an MGH Executive Committee on Research Tosteson and Fund for Medical Discovery Postdoctoral Fellowship award (Dr. Ma). Dr. Nishihara and Dr. Chan reported holding stocks and/or consulting for various sources.

Source: Ma W et al. JAMA Oncol. 2021 May 20. doi: 10.1001/jamaoncol.2021.1364 .

Recommended Reading

Age should not be a barrier to aggressive esophageal cancer treatment
MDedge Hematology and Oncology
Can smoke exposure inform CRC surveillance in IBD?
MDedge Hematology and Oncology
Swallowable capsule-camera may reveal GI cancers, diseases
MDedge Hematology and Oncology
Cumulative inflammatory burden predicts cancer risk in ulcerative colitis
MDedge Hematology and Oncology
FDA approves frontline immunotherapy for gastric cancers
MDedge Hematology and Oncology
First AI device for colonoscopy: Extra set of expert ‘eyes’
MDedge Hematology and Oncology
Does surgery for colorectal liver metastases release tumor cells?
MDedge Hematology and Oncology
CRC screening guidelines: 45 is the new 50, and 85 is the new 75
MDedge Hematology and Oncology
NPs and PAs performing colonoscopies: Why not?
MDedge Hematology and Oncology
Clinical Edge Journal Scan Commentary: Colorectal Cancer July 2021
MDedge Hematology and Oncology